Influence of tumor volume on survival in patients irradiated for non-small-cell lung cancer

International Journal of Radiation Oncology Biology Physics

Volumn 53, Issue 4, 2002, Pages 835-846

  Etiz, Durmus ^a,b   Marks, Lawrence B ^a   Zhou, Su Min ^d   Bentel, Gunilla C ^d   Clough, Robert ^a   Hernando, Maria L ^c   Lind, Pehr A ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Osmangazi University School of Medicine   (United States)

^c Makati Medical Center   (United States)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Non small cell lung cancer; Radiotherapy; Survival; Tumor volume

Indexed keywords

CELLS; COMPUTERIZED TOMOGRAPHY; RADIOTHERAPY; REGRESSION ANALYSIS;

THERAPEUTIC STUDIES;

TUMORS;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; COMPUTER ASSISTED RADIOTHERAPY; CONTROLLED STUDY; FEMALE; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; TREATMENT PLANNING; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 0037100139     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(02)02814-6     Document Type: Article

References (44)

1. Cancer statistics, 2000
2. Cancer statistics, 1992
3. Radiotherapy for patients with medically inoperable stage I nonsmall cell lung carcinoma: Smaller volumes and higher doses - A review
4. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: Update of a phase I trial
5. Concurrent hyperfractionated irradiation and chemotherapy for unresectable nonsmall cell lung cancer: Results of Radiation Therapy Oncology Group 90-15
6. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: A randomised multicentre trial
7. Improved survival in stage III non-small-cell lung cancer: Seven-year follow-up of cancer and leukemia group B (CALGB) 8433 trial
8. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: First analysis of a randomized trial in 353 patients
9. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: Preliminary results of a phase III trial in regionally advanced, unresectable non-small-cell lung cancer
10. Randomized trial of hyperfractionated radiation therapy with or without concurrent chemotherapy for stage III non-small-cell lung cancer
11. Hyperfractionated radiation therapy with or without concurrent low-dose daily carboplatin/etoposide for stage III non-small-cell lung cancer: A randomized study
12. Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer
13. Revisions in the International System for Staging Lung Cancer
14. Recursive partitioning analysis of 1592 patients on four Radiation Therapy Oncology Group studies in inoperable non-small cell lung cancer
15. Prognostic factors of inoperable localized lung cancer treated by high dose radiotherapy
16. Radiotherapy alone for medically inoperable stage I non-small-cell lung cancer: The Duke experience
17. The role of curative radiotherapy in the treatment of lung cancer
18. Pre-treatment prognostic factors in patients with stage III non-small cell lung cancer treated with hyperfractionated radiation therapy with or without concurrent chemotherapy
19. Volume and dose parameters for survival of non-small cell lung cancer patients
20. Gross tumor volume is an independent predictor of survival in non-small cell lung carcinoma patients treated with conformal radiotherapy
21. Prognostic factors in the treatment of node-negative nonsmall cell lung carcinoma with radiotherapy alone
22. The influence of tumor size and pre-treatment staging on outcome following radiation therapy alone for stage I non - Small cell lung cancer
23. Irradiation for inoperable carcinoma of the lung and high performance status
24. Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: Report by the Radiation Therapy Oncology Group
25. Radiotherapy as an alternative to surgery in elderly patients with resectable lung cancer
26. Radical radiotherapy for medically inoperable non-small cell lung cancer in clinical stage I: A retrospective analysis of 149 patients
27. A practical prognostic index for inoperable non-small-cell lung cancer
28. Estimation or quantification of tumour volume? CT study on irregular phantoms
29. The equivalent tissue-air ratio method for making absorbed dose calculations in a heterogeneous medium
30. Coordinate transformation as a primary representation of radiotherapy beam geometry
31. Treatment planning at the University of North Carolina at Chapel Hill
32. Virtual simulation: Initial clinical results
33. Lung corrections in cobalt 60 beam therapy
34. Experimental tests of corrections for tissue inhomogeneities in radiotherapy
35. High-dose, hyperfractionated, accelerated radiotherapy using a concurrent boost for the treatment of nonsmall cell lung cancer: Unusual toxicity and promising early results
36. 73.6 Gy and beyond: Hyperfractionated, accelerated radiotherapy for non-small-cell lung cancer
37. Prognostic implications of the International Staging System for Lung Cancer
38. Local control in medically inoperable lung cancer: An analysis of its importance in outcome and factors determining the probability of tumor eradication
39. Confirmation of a prognostic index for patients with inoperable non-small cell lung cancer
40. Evaluation of a target contouring protocol for 3D conformal radiotherapy in non-small cell lung cancer
41. Prognostic impact of total tumor volume and hemoglobin concentration on the outcome of patients with advanced head and neck cancer after concomitant boost radiochemotherapy
42. Nonparametric estimation of the size-metastasis relationship in solid cancers
43. Modeling tumor and treated lung volume influences in the irradiation of non-small-cell lung cancer patients